Furthermore, meclozine, an anti-histamine used to treat motion sickness, inhibits FGFR3 activity in chondrocyte cell lines and in a mouse model of achondroplasia, where it rescued the skeletal defects [98,99,100]. Here, FGFR3 is linked to achondroplasia.